MMS (Maximus) 2026 stock outlook. How the company runs Medicaid, Medicare and other public benefit programs under long government contracts, why renewal rates stay high, what happens after the Medicaid redetermination bump, and the political risks behind its low multiple.
Encompass Health (EHC) 2026 stock analysis: America's largest inpatient rehabilitation hospital (IRF) network, aging-population volume growth, the new-hospital and bed-expansion pipeline, scale advantages, the pure-play shift after the 2022 Enhabit spinoff, and the Medicare reimbursement and clinical-labor risks that decide the margin.
A practical 2026 guide to Medicare IRMAA, the income-related monthly adjustment amount on Part B and Part D. How MAGI sets the surcharge tiers, the 2-year lookback, the bracket cliff effect, which income counts, planning levers to stay under, and appealing with Form SSA-44.
DVA (DaVita) stock outlook for 2026. A qualitative deep dive into the US dialysis clinic duopoly, how the commercial-versus-Medicare payer mix drives margins, the long-run volume risks from GLP-1s, kidney transplants and home dialysis, plus Berkshire ownership and the aggressive buyback engine.
A clear guide to Medigap (Medicare Supplement insurance): what it covers beyond Original Medicare, how standardized plans like Plan G and Plan N differ, Medigap vs Medicare Advantage, the crucial 6-month Open Enrollment window, medical underwriting, and what really drives your premium.
Over half of Medicare beneficiaries are now on Medicare Advantage, but Medigap is often the smarter long-term choice. Here's the structural comparison, the open enrollment trap, and the specific situations where each option wins.
Elevance Health (ELV) 2026 investment analysis: 45.4M members, 86.8% MLR, $18B Carelon revenue, MA star ratings, IRA Part D $2,000 OOP cap, bull and bear scenarios vs. UNH, HUM, CI.
A practical breakdown of how US insurance covers GLP-1 drugs like Ozempic, Wegovy, Mounjaro, and Zepbound — including prior authorization requirements, how to appeal denials, Medicare Part D policy evolution, and what happens if the FDA removes compounding exemptions.
Comprehensive 2026 comparison of Medicare Advantage (Part C) vs Original Medicare — costs, networks, drug coverage, and when to switch. Make the best choice for your health and budget.